Sunday, April 26, 2015 8:35:43 PM
https://clinicaltrials.gov/ct2/results?term=cellceutix
Have you forgotten about Brilacidin and how quickly he got it into a phase 2b trial after the asset acquisition? Where would we be now in share price if he hadn’t picked that up and everyone was simply waiting on Kevetrin results? The man deserves credit.
See quotes from some of my recent posts this month and you'll see I don't agree with all he has done.
99189 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113102135&txt2find=leo
"Regarding Leo, there are things I would have done differently, however, overall, I'm quite pleased with how he has moved the company along."
98271 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112875138
“Leo has performed exceedingly well overall. There are a few things I'd have done differently, but, I'm not complaining. Look at the share price appreciation over the last few years. ;)”
In Reply to 'BobbyKIrk'
Karin after last week and Leo's credibility really starting to bring down this company , he needs to hit one out of the park for a change , stop defending him all the time let him bring this company back to where it was . A lot of people at one point really believed in him ,that's not the case anymore and he needs to make some positive changes in his PR releases . Leo is the leader of this company
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM